Medicare Benefits Schedule item numbers for transcranial magnetic stimulation (TMS): Questions arising

OBJECTIVE: Four Medicare Benefits Schedule item numbers for Transcranial Magnetic Stimulation (TMS) treatment of unresponsive MDD were declared in Australia in 2021. They are accompanied by rules/conditions. The aim is to consider these rules/conditions in light of recent research and real-world exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Pridmore, Saxby, Pridmore, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Neurostimulation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466937/
https://www.ncbi.nlm.nih.gov/pubmed/37128938
http://dx.doi.org/10.1177/10398562231173228
Descripción
Sumario:OBJECTIVE: Four Medicare Benefits Schedule item numbers for Transcranial Magnetic Stimulation (TMS) treatment of unresponsive MDD were declared in Australia in 2021. They are accompanied by rules/conditions. The aim is to consider these rules/conditions in light of recent research and real-world experience. CONCLUSIONS: While evidence supports some listed rules/conditions, others lack clinical justification and deserve to be reconsidered. These include (a) ineligibility of patients who have previously received TMS, (b) a lifetime total limit of 50 treatments, (c) a second/final course being unavailable for 4 months following the completion of the first course, and (d) the second/final course being limited to 15 treatments.

Ejemplares similares